close

Enter

Log in using OpenID

Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

embedDownload
According to a new market report published by Transparency Market Research “Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the global mice model market was valued at USD 1.01 billion in 2013 and
Transparency Market
Research
Mice Model Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast 2015 - 2023
Published Date
03-Sep-2015
155 Page Report
Buy Now
Request Sample
Press Release
Mice Model Market expected to reach USD 1.75 Billion in 2023 :
Transparency Market Research
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
[email protected]
Mice Model Market
REPORT DESCRIPTION
Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 2023
According to a new market report published by Transparency Market Research “Mice Model Market - Global
Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the global mice model market
was valued at USD 1.01 billion in 2013 and is anticipated to expand at a CAGR of 6.4% from 2015 to 2023
to reach USD 1.75 billion by 2023.
Browse the full report at
http://www.transparencymarketresearch.com/mice-model-market.html
Mice have been one of the most important research tools for basic and applied research in biomedical
sciences and continues to grow at a rapid rate. Besides providing precise correlation with human condition,
the major advantage of mice models is the prospect of exploring precise gene-specific functions and
various molecular events in a living organism. Combining mice models with advanced imaging
technologies provide unique opportunities to understand the etiology and pathophysiology of human
diseases. Furthermore, mice have been widely used in biomedical research to discover human diseases
and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of
diseases and conditions. For example, experiments on mice models resulted in efficacious treatments for
acute promyelocytic leukemia, or APL, which was largely terminal.
Browse Press Release Of This Report:http://www.transparencymarketresearch.com/pressrelease/mice-model-market.htm
The global mice model market has been segmented on the basis of model type, specialty, services, and
geography. Based on model type, the market has been segmented into hybrid/congenic, transplantation
mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and
conditioned/surgically modified. Inbred was the largest segment of the global mice model market in 2014
due to advantages such as cost effectiveness and data reproducibility. Moreover, the hybrid/congenic
segment is expected to expand at the highest CAGR during the forecast period from 2015 to 2023 due to
increasing applications in immunology, oncology, and cardiovascular studies. Based on specialty, the
market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes,
and metabolism & regulation. Metabolic & regulatory diseases was the largest specialty segment of the
market in terms of revenue in 2014. The diabetes mice models specialty segment is likely to expand at the
highest growth rate due to rising prevalence of the disease across the globe, particularly in developed
countries. Some of the prominent services offered to end-users include breeding and rederivation,
cryopreservation and cryorecovery, quarantine services, genetic testing, model in-licensing, in vivo and in
Transparency Market Research
2
Mice Model Market
vitro pharmacology services, genetically engineered model services, and other services such as surgical
and line rescue. The major factor influencing the growth of the services market is the growing importance
of customized models in applied research as well as in the development and production of vital
biomolecules.
Get Sample Report Copy with TOC and Market Research :
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085
Key players operating in the global mice model market include Charles River Laboratories, Crescendo
Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic
Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, and TransGenic, Inc.
The global mice model market has been segmented as follows:
•
•
•
Global Mice Model Market, by Type
•
Transgenic Mice Model
•
Hybrid/Congenic Mice Model
•
Knockout Mice Model
•
Carcinogen/induced and Spontaneous Mice Model
•
Outbred Mice Model
•
Inbred Mice Model
•
Transplantation Mice Model
•
Conditioned/Surgically Modified Mice Model
Global Mice Model Market, by Specialty
•
Immunology
•
Central Nervous System
•
Oncology
•
Cardiovascular
•
Diabetes
•
Metabolism & Regulation
Global Mice Model Market, by Services
Transparency Market Research
3
Mice Model Market
•
•
Breeding and Rederivation Services
•
Cryopreservation and Cryorecovery Services
•
Quarantine Services
•
Genetic Testing Services
•
Model In-licensing Services
•
In vivo and In vitro Pharmacology Services
•
Other Services (Surgical and Line Rescue)
Global Mice Model Market, by Geography
•
•
•
•
•
North America
•
U.S.
•
Canada
Europe
•
Germany
•
U.K.
•
Rest of Europe
Asia Pacific (APAC)
•
Japan
•
China
•
Rest of APAC
Latin America (LATAM)
•
Brazil
•
Mexico
•
Rest of LATAM
Middle East & North Africa (MENA)
•
Saudi Arabia
•
UAE
•
Israel
Transparency Market Research
0
Mice Model Market
•
•
Rest of MENA
Rest of the World (RoW)
Related & Recently Published Report by Transparency Market Research
E.coli Testing Market :
http://www.transparencymarketresearch.com/e-coli-testing-market.html
TABLE OF CONTENT
Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.2.1 Secondary Research
1.2.2 Primary Research
1.3 Market Segmentation
1.4 Assumptions and Stipulations
Chapter 2 Executive Summary
2.1 Global Mice Consumption, 2013
2.2 Market Snapshot: Global Mice Model Market (2014 and 2023E)
2.3 Global Mice Model Market, by Type, 2014 (USD Million)
2.4 Global Mice Model Market, by Application, 2014 (USD Million)
2.5 Global Mice Model Market, by Services, 2014 (USD Million)
2.6 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2014 and 2023E (Value %)
Transparency Market Research
1
Mice Model Market
Chapter 3 Global Mice Model Market: Market Overview
3.1 Overview
3.1.1 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
3.2 End-users of Mice Models
3.2.1 End-user Analysis of Mice Model Market (Value %), 2013
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Growing investment in biomedical research
3.3.1.2 Biomedical Research Growth Rate, 2007–2012, (%)
3.3.1.3 Growing number of advanced mice model would increase applicability and acceptability
3.3.1.4 Personalized in vivo analysis mice models would fuel demand for mice models in
personalized medicine
3.3.2 Restraints
3.3.2.1 Rising concern about animal use across the globe would restrain the market
3.3.2.2 Development of alternative technologies
3.3.3 Opportunities
3.3.3.1 Countries in Asia offer immense growth opportunities in the mice model market
3.4 Event Impact Assessment: Mice Model Market
3.5 Market Attractiveness Analysis: Global Mice Model Market
3.5.1 Mice Model Market Analysis: The U.S. and China
3.5.2 Market Attractiveness Analysis: Global Mice Model Market, by Geography
3.5.3 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
3.6 Competitive Landscape
3.6.1 Global Market Share Analysis, by Key Players, 2013 (Value %)
3.6.2 Global Market Share Analysis, by Key Players, 2014 (Value %)
3.6.3 Heat Map Analysis, by Key Geography, 2014 (Market Share)
3.6.4 Heat Map Analysis, by Key Geography, 2014 (Market Growth)
Transparency Market Research
2
Mice Model Market
Chapter 4 Global Mice Model Market, by Type
4.1 Overview
4.1.1 Global Mice Model Market, by Type, 2013–2014 (USD Million)
4.1.2 Global Mice Model Market, by Model Type, 2015E–2023E (USD Million)
4.2 Transgenic Mice Model
4.2.1 Transgenic Mice Applications in Various Specialties (%)
4.2.2 Global Transgenic Mice Model Market, 2013–2023E (USD Million)
4.3 Hybrid/Congenic Mice Model
4.3.1 Global Hybrid/Congenic Mice Model Market, 2013–2023E (USD Million)
4.4 Knockout Mice Model
4.4.1 Knockout Mice Applications in Various Specialties, 2014 (%)
4.4.2 Global Knockout Mice Model Market, 2013–2023E (USD Million)
4.5 Carcinogen-induced and Spontaneous Mice Model
4.5.1 Global Carcinogen-induced and Spontaneous Mice Model Market, 2013–2023E (USD Million)
4.6 Outbred Mice Model
4.6.1 Global Outbred Mice Model Market, 2013–2023E (USD Million)
4.7 Inbred Mice Model
4.7.1.1 Inbred Mice Applications in various Specialties (%), 2014
4.7.1.2 Global Inbred Mice Model Market, 2013–2023E (USD Million)
4.8 Transplantation Mice Model
4.8.1 Global Transplantation Mice Model Market, 2013–2023E (USD Million)
4.9 Conditioned/Surgically Modified Mice Model
4.9.1 Global Conditioned/Surgically Modified Mice Model Market, 2013–2023E (USD Million)
Chapter 5 Global Mice Model Market, by Specialty
5.1 Overview
5.1.1 Global Mice Model Market, by Application, 2013–2014 (USD Million)
5.1.2 Global Mice Model Market, by Application, 2015E–2023E (USD Million)
Transparency Market Research
3
Mice Model Market
5.2 Immunology
5.2.1 Global Immunology Mice Model Market, 2013–2023E (USD Million)
5.2.2 Number of Immunology Mice Models, by Major Companies
5.2.3 Immunology Mice Model Market Share, by Model Type, 2014
5.3 Central Nervous System (CNS)
5.3.1 Global CNS Mice Model Market, 2013–2023E (USD Million)
5.3.2 Number of CNS Mice Models, by Major Companies
5.3.3 CNS Mice Model Market Share, by Model Type, 2014
5.4 Oncology
5.4.1 Global Oncology Mice Model Market, 2013–2023E (USD Million)
5.4.2 Number of Oncology Mice Models, by Major Companies
5.4.3 Oncology Mice Model Market Share, by Model Type, 2014
5.5 Cardiovascular
5.5.1 Global Cardiovascular Mice Model Market, 2013–2023E (USD Million)
5.5.2 Number of Cardiovascular Mice Models, by Major Companies
5.5.3 Cardiovascular Mice Model Market Share, by Model Type, 2014
5.6 Diabetes
5.6.1 Global Diabetes Mice Model Market, 2013–2023E (USD Million)
5.6.2 Number of Diabetes Mice Models, by Major Companies
5.6.3 Diabetes Mice Model Market Share, by Model Type, 2014
5.7 Metabolism & Regulation
5.7.1 Global Metabolism & Regulation Mice Model Market, 2013–2023E (USD Million)
5.7.2 Metabolism & Regulation Mice Models Market Share, by Model Type, 2014
Chapter 6 Global Mice Model Market, by Services
6.1 Overview
6.1.1 Global Mice Model Market, by Services, 2013–2014 (USD Million)
6.1.2 Global Mice Model Market, by Services, 2015E–2023E (USD Million)
Transparency Market Research
4
Mice Model Market
6.2 Breeding and Rederivation Services
6.2.1 Global Breeding and Rederivation Services Market, 2013–2023E (USD Million)
6.3 Cryopreservation and Cryorecovery Services
6.3.1 Global Cryopreservation and Cryorecovery Services Market, 2013–2023E (USD Million)
6.4 Quarantine Services
6.4.1 Global Quarantine Services Market, 2013–2023E (USD Million)
6.5 Genetic Testing Services
6.5.1 Global Genetic Testing Services Market, 2013–2023E (USD Million)
6.6 Model In-licensing Services
6.6.1 Global Model In-licensing Market, 2013–2023E (USD Million)
6.7 In vivo and In vitro Pharmacology Services
6.7.1 Global In vivo and In vitro Pharmacology Services Market, 2013–2023E (USD Million)
6.8 Genetically Engineered Model Services
6.8.1 Genetically Engineered Model Services
6.9 Other Services (Surgical and Line Rescue)
6.9.1 Global Other Services Market, 2013–2023E (USD Million)
Chapter 7 Global Mice Model Market, by Geography
7.1 Overview
7.1.1 Mice Model Market Share Index, 2014 (On Scale of 1 to 5)
7.1.2 Global Mice Model Market, Growth Index, 2015–2023 (On a Scale of 1 to 5)
7.1.3 Global Mice Model Market Revenue, by Geography, 2013–2023 (USD Million)
7.2 North America
7.2.1 North America Population, GDP, and Health care Expenditure, 2011–2013
7.2.2 North America Mice Model Market Revenue, 2013–2023E (USD Million
7.2.3 U.S.
7.2.3.1 U.S. Mice Model Market, 2013–2023E (USD Million)
7.2.4 Canada
Transparency Market Research
5
Mice Model Market
7.2.4.1 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012
(Value %)
7.2.4.2 Canada Mice Model Market, 2013–2023E (USD Million)
7.3 Europe
7.3.1 Europe Population, GDP, and Health care Expenditure, 2011–2013
7.3.2 Europe Mice Model Market Revenue, 2013–2023E (USD Million)
7.3.3 Germany
7.3.3.1 Germany Mice Model Market Revenue, 2013–2023E (USD Million)
7.3.4 U.K.
7.3.4.1 U.K. Mice Model Market Revenue, 2013–2023E (USD Million)
7.3.5 Rest of Europe
7.3.5.1 Rest of Europe Mice Model Market Revenue, 2013–2023E (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2013
7.4.2 Asia Pacific Mice Model Market Revenue, 2013–2023E (USD Million)
7.4.3 Japan
7.4.3.1 Japan Mice Model Market, 2013–2023E (USD Million)
7.4.4 China
7.4.4.1 China Mice Model Market, 2013–2023E (USD Million)
7.4.5 Rest of Asia Pacific
7.4.5.1 Rest of Asia Pacific Mice Model Market, 2013–2023E (USD Million)
7.5 Latin America
7.5.1 Latin America Population, GDP, and Health care Expenditure, 2011 – 2013
7.5.2 Latin America Mice Model Market, 2013–2023E (USD Million)
7.5.3 Brazil
7.5.3.1 Brazil Mice Model Market, 2013–2023E (USD Million)
7.5.4 Mexico
7.5.4.1 Mexico Mice Model Market, 2013–2023E (USD Million)
Transparency Market Research
6
Mice Model Market
7.5.5 Rest of Latin America
7.5.5.1 Rest of Latin America Mice Model Market, 2013–2023E (USD Million)
7.6 Middle East & North Africa (MENA)
7.6.1 MENA Mice Model Market, 2013–2023E (USD Million)
7.6.2 Saudi Arabia (KSA)
7.6.2.1 Saudi Arabia Mice Model Market, 2013–2023E (USD Million)
7.6.3 UAE
7.6.3.1 UAE Mice Model Market, 2013–2023E (USD Million)
7.6.4 Israel
7.6.4.1 Israel Mice Model Market, 2013–2023E (USD Million)
7.6.5 Rest of MENA
7.6.5.1 Rest of MENA Mice Model Market, 2013–2023E (USD Million)
7.7 Rest of the World (RoW)
7.7.1 RoW Population, GDP, and Health care Expenditure, 2011–2013
7.7.2 Rest of World Mice Model Market, 2013–2023E (USD Million)
Chapter 8 Recommendations
8.1 Focus on collaborations with contract research organizations or strengthening in-house research
capabilities
8.2 Sustaining pricing pressures in a declining global economic scenario
8.3 Investing in emerging markets such as India, China, and Brazil
Chapter 9 Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
Transparency Market Research
7
Mice Model Market
9.1.5 Recent Developments
9.2 Crescendo Biologics Limited
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Deltagen, Inc.
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 genOway S.A.
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Harbour Antibodies BV
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Harlan Laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
Transparency Market Research
8
Mice Model Market
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 ImmunoGenes AG
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 SAGE Labs
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 The Jackson Laboratory
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Taconic Biosciences, Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 TransGenic, Inc.
Transparency Market Research
9
Mice Model Market
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
Browse All Biotechnology Market Research Reports @
http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html
About Us
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use
proprietary data sources and various tools and techniques to gather, and analyze information. Our
business offerings represent the latest and the most reliable information indispensable for businesses to
sustain a competitive edge.
Contact
Mr. Nachiket Ghumare
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
Transparency Market Research
10
1/--pages
Report inappropriate content